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Introduction {#jgh312207-sec-0005}
============

Inflammatory bowel diseases (IBD) are chronic relapsing and remitting inflammatory diseases of the gastrointestinal tract. Most patients achieve drug‐induced disease remission, but approximately 15% of those with ulcerative colitis (UC) require removal of the colon within 10 years of diagnosis.[1](#jgh312207-bib-0001){ref-type="ref"} Proctocolectomy with ileoanal pouch formation is the most commonly applied surgical treatment, designed to avoid the negative physical and psychosocial effects of a permanent stoma.[2](#jgh312207-bib-0002){ref-type="ref"}

Many patients continue to experience troublesome bowel symptoms, including fecal urgency, increased bowel frequency, fecal incontinence, constipation (low bowel frequency or impaired rectal evacuation), abdominal pain, or bloating, despite apparent drug‐ or surgically induced disease remission.[3](#jgh312207-bib-0003){ref-type="ref"}, [4](#jgh312207-bib-0004){ref-type="ref"}, [5](#jgh312207-bib-0005){ref-type="ref"} Fecal incontinence is a key concern for people with IBD.[6](#jgh312207-bib-0006){ref-type="ref"}, [7](#jgh312207-bib-0007){ref-type="ref"} The prevalence of fecal incontinence in patients with IBD ranges from 24 to 74% and occurs during active and quiescent disease phases.[8](#jgh312207-bib-0008){ref-type="ref"}, [9](#jgh312207-bib-0009){ref-type="ref"}, [10](#jgh312207-bib-0010){ref-type="ref"}, [11](#jgh312207-bib-0011){ref-type="ref"}, [12](#jgh312207-bib-0012){ref-type="ref"} Incontinence rates in patients with a pouch vary from 4 to 55% overnight and 4 to 40% during the day.[13](#jgh312207-bib-0013){ref-type="ref"}, [14](#jgh312207-bib-0014){ref-type="ref"} Constipation occurs in 26% of those with UC and 6% in those with Crohn\'s disease during remission.[3](#jgh312207-bib-0003){ref-type="ref"} Evacuation difficulty has been reported in 9--40% of patients with an ileoanal pouch,[15](#jgh312207-bib-0015){ref-type="ref"}, [16](#jgh312207-bib-0016){ref-type="ref"}, [17](#jgh312207-bib-0017){ref-type="ref"} increasing with age.[15](#jgh312207-bib-0015){ref-type="ref"} Despite the high prevalence, these symptoms are underreported by patients and underrecognized by clinicians.[9](#jgh312207-bib-0009){ref-type="ref"}, [18](#jgh312207-bib-0018){ref-type="ref"}, [19](#jgh312207-bib-0019){ref-type="ref"}

A complex interaction of physiological and psychological factors is most likely involved in the generation and perpetuation of functional bowel symptoms following disease remission.[3](#jgh312207-bib-0003){ref-type="ref"}, [20](#jgh312207-bib-0020){ref-type="ref"}, [21](#jgh312207-bib-0021){ref-type="ref"}, [22](#jgh312207-bib-0022){ref-type="ref"} Alterations in gut motility, rectal or pouch compliance (stiffness), sensitivity, and contractility occurring in response to the inflammatory process or pouch surgery are implicated in symptom generation.[23](#jgh312207-bib-0023){ref-type="ref"}, [24](#jgh312207-bib-0024){ref-type="ref"}, [25](#jgh312207-bib-0025){ref-type="ref"}, [26](#jgh312207-bib-0026){ref-type="ref"} Patients with fistulizing Crohn\'s disease or an ileoanal pouch may have poor anal sphincter function, further compromising bowel function.[27](#jgh312207-bib-0027){ref-type="ref"}, [28](#jgh312207-bib-0028){ref-type="ref"} Psychological stress affects gut motility, visceral sensation, and immune factors and can exacerbate or perpetuate symptoms.[20](#jgh312207-bib-0020){ref-type="ref"}, [29](#jgh312207-bib-0029){ref-type="ref"}, [30](#jgh312207-bib-0030){ref-type="ref"} Persistent symptoms are associated with anxiety, depression, health‐care utilization, absenteeism, and impaired health‐related quality of life.[3](#jgh312207-bib-0003){ref-type="ref"}, [31](#jgh312207-bib-0031){ref-type="ref"}, [32](#jgh312207-bib-0032){ref-type="ref"}, [33](#jgh312207-bib-0033){ref-type="ref"}, [34](#jgh312207-bib-0034){ref-type="ref"}

Normal pelvic floor muscle function is integral to the maintenance of bowel control (continence) and evacuation of stool (defecation).[35](#jgh312207-bib-0035){ref-type="ref"} Pelvic floor muscle dysfunction may be a learned "maladaptive" behavior in response to unpleasant stimuli such as abdominal or anorectal pain, loose stools, and fecal urgency, which are common in patients with IBD.[36](#jgh312207-bib-0036){ref-type="ref"} Defecation is impaired when the pelvic floor and anal sphincter muscles contract or fail to relax adequately during evacuation. This is referred to as dyssynergia, paradoxical puborectalis contraction, or nonrelaxing pelvic floor muscle dysfunction.[37](#jgh312207-bib-0037){ref-type="ref"}, [38](#jgh312207-bib-0038){ref-type="ref"} Pelvic floor muscle dysfunction has been identified in over half the patients with an ileoanal pouch[39](#jgh312207-bib-0039){ref-type="ref"}, [40](#jgh312207-bib-0040){ref-type="ref"} and between 45 and 97% of patients with quiescent IBD and symptoms of evacuation difficulty.[41](#jgh312207-bib-0041){ref-type="ref"}, [42](#jgh312207-bib-0042){ref-type="ref"}

Functional bowel symptoms are therefore a major problem for patients with IBD, but their management has received little attention. Typically, treatment is empirical and includes drug therapy, dietary modification, or psychological therapies.[43](#jgh312207-bib-0043){ref-type="ref"} None of these therapies directly target the maladaptive toileting behavior or pelvic floor muscle dysfunction. Pelvic floor muscle training with biofeedback has been suggested as a treatment option for patients with IBD, but the efficacy of this approach is unclear.[40](#jgh312207-bib-0040){ref-type="ref"}, [41](#jgh312207-bib-0041){ref-type="ref"}, [42](#jgh312207-bib-0042){ref-type="ref"}, [44](#jgh312207-bib-0044){ref-type="ref"} Pelvic floor muscle training, with or without biofeedback, has been extensively investigated and used successfully to treat bowel dysfunction in patients without IBD.[45](#jgh312207-bib-0045){ref-type="ref"}, [46](#jgh312207-bib-0046){ref-type="ref"}, [47](#jgh312207-bib-0047){ref-type="ref"} However, there are very limited data supporting efficacy in the setting of IBD. This review aimed to systematically evaluate the evidence for pelvic floor muscle training in the management of bowel symptoms suggestive of dysfunction in patients with IBD in disease remission.

Methods {#jgh312207-sec-0006}
=======

This systematic review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta‐analyses guidelines.[48](#jgh312207-bib-0048){ref-type="ref"}

*Literature search strategy* {#jgh312207-sec-0007}
----------------------------

Six electronic databases (MEDLINE 1946--2018, EMBASE 1980--2018, CINAHL 1982--2018, PEDro 1999--2018, PsycINFO 1946--2018, and the Cochrane Library 2018) were searched systematically in March 2018. Conference abstracts from the following journals were also searched: Journal of Crohn\'s Colitis, Inflammatory Bowel Diseases, Diseases of the Colon and Rectum, Colorectal Disease, Gut; Journal of Gastroenterology and Hepatology; and the United European Gastroenterology Journal.

The search strategy used combinations of the following MeSH headings and keywords: inflammatory bowel disease, Crohn or Crohn\'s disease, ulcerative colitis, proctocolectomy restorative, colonic pouches, ileoanal reservoir, ileal pouch anal anastomosis, ileoanal pouch, J pouch, IPAA, biofeedback psychology, electromyography (EMG), physical therapy modalities, physiotherapy, physical therapy, behavior therapy, rehabilitation, pelvic floor muscle, levator ani, puborectalis, fecal incontinence, constipation, and defecation. Articles were limited to those published in full in English. Reference lists of selected articles and conference abstracts between 2013 and 2018 were also checked, and relevant abstracts were followed up to determine if the data had been published in a full paper.

*Study selection criteria* {#jgh312207-sec-0008}
--------------------------

Studies were included if they met the following eligibility criteria:

### *Study design* {#jgh312207-sec-0009}

Randomized controlled trials (RCTs), cohort studies, or case series reports.

### *Participants* {#jgh312207-sec-0010}

Adults ≥18 years of age with IBD in disease remission, defined clinically, endoscopically, or histologically, or with an ileoanal pouch but no pouch inflammation. Patients were included with symptoms of fecal urgency or incontinence and evacuation difficulty or constipation. Patients with an ileoanal pouch before stoma closure were also included to determine whether behavioral treatment prior to stoma closure would prevent or reduce bowel symptoms after stoma closure.

### *Intervention* {#jgh312207-sec-0011}

Pelvic floor, Kegel, or anal sphincter muscle exercises with or without biofeedback. Training methods vary and can include exercises focused on strength training, sensory training, and/or coordination or simulated defecation training. "Biofeedback" is just one of the training tools used to provide information to the patient about muscle performance and changes made with the training program.

### *Outcomes* {#jgh312207-sec-0012}

The primary outcome reported was bowel function using any of the following measures: bowel diary, patient rating of improvement, or a validated questionnaire.

One author (Angela J Khera) screened all titles and abstracts to identify potential studies for inclusion. Two reviewers (Angela J Khera and Janet W Chase) independently evaluated the abstracts and full texts of all retrieved papers to decide eligibility. A third reviewer (Michael A Kamm) resolved any disagreements.

*Data extraction* {#jgh312207-sec-0013}
-----------------

Extracted data were recorded on a review‐specific form and included the first author\'s name, publication year, study design, number of participants, age, gender, IBD diagnosis, presenting symptoms, details of the intervention type, outcome measures, training frequency, duration of training program, dropouts, follow‐up period, and results.

*Quality appraisal* {#jgh312207-sec-0014}
-------------------

Methodological quality was assessed independently by two reviewers (Janet W Chase and Angela J Khera) using the Methodological Index for Non‐Randomized Studies (MINORS) tool[49](#jgh312207-bib-0049){ref-type="ref"} and the Cochrane Risk of Bias Tool[50](#jgh312207-bib-0050){ref-type="ref"} for RCTs. MINORS is a validated tool assessing nonrandomized studies using eight criteria, each allocated a score of 0--2 per item (0 = not reported, 1 = reported but inadequate, 2 = reported and adequate). Items include study aim, inclusion criteria, nature of data collection, end‐points, blinding of assessment, follow‐up period, dropout reporting, and study size calculation. The Cochrane risk‐of‐bias tool for randomized trials assesses seven domains: random sequence generation, allocation concealment, blinding of participants and personnel, blinding of outcome assessment, incomplete outcome data, selective reporting, and other sources of bias. "High," "low,' or "unclear" risk of bias was determined by set criteria within each domain.[50](#jgh312207-bib-0050){ref-type="ref"} Papers were assigned an overall quality rating (poor, fair, good, excellent) based on the assessed criteria and reviewer consensus.

Results {#jgh312207-sec-0015}
=======

*Study selection* {#jgh312207-sec-0016}
-----------------

Following the electronic database search, a total of 4450 studies were identified, and a further 4 were found from hand searching. Titles and abstracts were screened after duplicates were removed, leaving nine studies to be assessed for eligibility. Seven studies meeting eligibility criteria were finally included for review (Fig. [1](#jgh312207-fig-0001){ref-type="fig"}).

![Diagram of study selection process. IBD, inflammatory bowel disease.](JGH3-3-494-g001){#jgh312207-fig-0001}

*Study characteristics* {#jgh312207-sec-0017}
-----------------------

### *Study design* {#jgh312207-sec-0018}

Two RCTs,[51](#jgh312207-bib-0051){ref-type="ref"}, [52](#jgh312207-bib-0052){ref-type="ref"} one prospective observational study,[53](#jgh312207-bib-0053){ref-type="ref"} and four retrospective case series[39](#jgh312207-bib-0039){ref-type="ref"}, [42](#jgh312207-bib-0042){ref-type="ref"}, [54](#jgh312207-bib-0054){ref-type="ref"}, [55](#jgh312207-bib-0055){ref-type="ref"} were included.

### *Participants* {#jgh312207-sec-0019}

A total of 227 participants (females 58%) were included in the studies, of whom 134 had an intervention including pelvic floor or anal sphincter muscle training. Thirty‐one participants who had training had IBD in remission,[42](#jgh312207-bib-0042){ref-type="ref"}, [54](#jgh312207-bib-0054){ref-type="ref"} and 103 had an ileoanal pouch.[39](#jgh312207-bib-0039){ref-type="ref"}, [51](#jgh312207-bib-0051){ref-type="ref"}, [52](#jgh312207-bib-0052){ref-type="ref"}, [53](#jgh312207-bib-0053){ref-type="ref"}, [55](#jgh312207-bib-0055){ref-type="ref"} Thirty‐three participants were in control groups,[51](#jgh312207-bib-0051){ref-type="ref"}, [52](#jgh312207-bib-0052){ref-type="ref"} 57 were not referred for therapy,[39](#jgh312207-bib-0039){ref-type="ref"}, [42](#jgh312207-bib-0042){ref-type="ref"} and 3 dropped out before treatment commenced.[42](#jgh312207-bib-0042){ref-type="ref"}, [51](#jgh312207-bib-0051){ref-type="ref"}

Participants in the RCTs (*n* = 66) had ileoanal pouch surgery for UC and were asymptomatic as training occurred prior to stoma reversal.[51](#jgh312207-bib-0051){ref-type="ref"}, [52](#jgh312207-bib-0052){ref-type="ref"} Participants in the nonrandomized trials presented with symptoms including evacuation difficulty (*n* = 76), fecal incontinence (*n* = 25), abdominal pain (*n* = 1), and pruritus (*n* = 1).[39](#jgh312207-bib-0039){ref-type="ref"}, [42](#jgh312207-bib-0042){ref-type="ref"}, [54](#jgh312207-bib-0054){ref-type="ref"}, [55](#jgh312207-bib-0055){ref-type="ref"} Anal sphincter or pelvic floor muscle function was assessed prior to training with anal physiological testing including manometry, balloon expulsion or anal EMG.

Screening for IBD activity occurred in both IBD studies, and all patients were cleared of active left‐sided disease, with both endoscopy and histology, prior to pelvic floor muscle training.[42](#jgh312207-bib-0042){ref-type="ref"}, [54](#jgh312207-bib-0054){ref-type="ref"} The exclusion of pouchitis prior to training was not uniformly described. One study reported that physical examination was performed to exclude physical abnormalities but did not explicitly state that pouchitis was excluded.[53](#jgh312207-bib-0053){ref-type="ref"} Quinn *et al*.[39](#jgh312207-bib-0039){ref-type="ref"} performed endoscopy to assess pouch inflammation but did not state whether those treated with biofeedback had active pouchitis or not. Details of screening for pouchitis prior to biofeedback treatment were not reported in another study.[55](#jgh312207-bib-0055){ref-type="ref"} Participant characteristics are listed in Table [1](#jgh312207-tbl-0001){ref-type="table"}.

###### 

Participant characteristics

  Author, year                                                       Participants, *n*                                                   Diagnosis, *n*                               Male: Female                                 Age, years                         Symptoms and investigations
  ------------------------------------------------------------------ ------------------------------------------------------------------- -------------------------------------------- -------------------------------------------- ---------------------------------- -----------------------------------------------------------------------------------------------------------------------------------------------------------------
  Perera *et al*., 2013[42](#jgh312207-bib-0042){ref-type="ref"}     Total 30                                                            CD 24                                        6: 24                                        Mean (SD) 42.1 (12.75)             Evacuation difficulty Dyssynergic defecation demonstrated by anal manometry and balloon expulsion testing
  Training 22/30                                                                                                                                                                                                                                                      
  23 referred for therapy;                                           UC 6                                                                                                                                                                                             
  22 attended                                                                                                                                                                                                                                                         
  Vasant *et al*., 2017[54](#jgh312207-bib-0054){ref-type="ref"}     Total 9                                                             CD 6                                         2: 7                                         Median 53 (IQR 7)                  Fecal incontinence Anal manometry findings:
  9/9 external anal sphincter weakness                                                                                                                                                                                                                                
  Training 9/9                                                       UC 3                                                                6/9 internal sphincter weakness                                                                                              
  8/9 rectal hypersensitivity                                                                                                                                                                                                                                         
  Oresland *et al*., 1988[51](#jgh312207-bib-0051){ref-type="ref"}   Total 40                                                            Pouch (UC 40)                                18: 20                                       Training Mean 36(range,19--58)     Asymptomatic (prestoma reversal) Anal manometry performed pre‐ and postoperatively up to 12 months after ileostomy closure
  Training 18/20                                                                                                                                                                                                                                                      
  Two withdrawn with postoperative complications                     Control Mean 38 (range,18--51)                                                                                                                                                                   
  Control 20/20                                                                                                                                                                                                                                                       
  Jorge *et al*., 1994[52](#jgh312207-bib-0052){ref-type="ref"}      Total 26                                                            Pouch (UC 26)                                16: 10                                       Training Mean 33 (range, 17--56)   Asymptomatic (prestoma reversal) Anal manometry performed prior to the pouch procedure and again prior to ileostomy closure
  Training 13/13                                                     Control Mean 38 (range, 24--69)                                                                                                                                                                  
  Control 13/13                                                                                                                                                                                                                                                       
  Hull *et al*., 1995[53](#jgh312207-bib-0053){ref-type="ref"}       Total 13                                                            Pouch (UC 4, CD 4, others 5)                 7: 6                                         Not reported                       Evacuation dysfunction Paradoxical puborectalis contraction demonstrated on EMG
  Training 13/13                                                                                                                                                                                                                                                      
  Quinn *et al*., 2017[39](#jgh312207-bib-0039){ref-type="ref"}      Total (with pelvic floor dysfunction) 83/111                        Pouch (UC 100, others 11)                    49: 62                                       Median 44 (range, 15--75)          Evacuation difficulty Pelvic floor dyssynergia identified by one or more of the following: anal manometry, balloon expulsion testing, defecography, or anal EMG
  Training 33/83 No details on other 50                              Diagnosis not reported separately for training group; CD excluded   Not reported separately for training group   Not reported separately for training group                                      
  Segal *et al*., 2018[55](#jgh312207-bib-0055){ref-type="ref"}      Total 26                                                            Pouch (UC 23, others 3)                      8: 18                                        Median 49 (range, 36--74)          Fecal incontinence 26 Evacuation difficulty 8 (Other symptoms 2)
  Training 26/26                                                     Assessment methods not reported                                                                                                                                                                  

CD, Crohn\'s disease; EMG, electromyography; IQR, interquartile range; UC, ulcerative colitis.

### *Intervention* {#jgh312207-sec-0020}

The intervention varied in the type of training delivered, the duration, and the frequency and number of sessions (Table [2](#jgh312207-tbl-0002){ref-type="table"}). The pelvic floor muscles, particularly puborectalis, and the anal sphincter muscles act as a functional unit and are considered together in this review. Four studies provided details of biofeedback‐assisted training using EMG, anal pressure, or balloon manometry, while two studies did not provide any details about the type of biofeedback used.[39](#jgh312207-bib-0039){ref-type="ref"}, [55](#jgh312207-bib-0055){ref-type="ref"} Training involved pelvic floor exercises alone in one study.[52](#jgh312207-bib-0052){ref-type="ref"} Programs included strength training,[51](#jgh312207-bib-0051){ref-type="ref"}, [52](#jgh312207-bib-0052){ref-type="ref"}, [54](#jgh312207-bib-0054){ref-type="ref"} simulated defecation training,[42](#jgh312207-bib-0042){ref-type="ref"}, [53](#jgh312207-bib-0053){ref-type="ref"}, [54](#jgh312207-bib-0054){ref-type="ref"} repeated pouch balloon dilations,[51](#jgh312207-bib-0051){ref-type="ref"} or urge resistance training.[55](#jgh312207-bib-0055){ref-type="ref"}

###### 

Intervention

+--------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------+----------------+-----------------------------------+------------------+--------------------+
| Author, year                                                                                                       | Intervention program                                                                                                                                  | Duration (min) | Session frequency                 | Treatment period | Number of sessions |
+:===================================================================================================================+:======================================================================================================================================================+:===============+:==================================+:=================+:===================+
| Perera *et al*., 2013[42](#jgh312207-bib-0042){ref-type="ref"}                                                     | Outpatient biofeedback with either perianal surface electrodes or internal anal electrode EMG performed seated                                        | 30--60         | Once weekly                       | 4--6 weeks       | Maximum 6          |
+--------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------+----------------+-----------------------------------+------------------+--------------------+
| Isolated pelvic floor muscle contractions                                                                          |                                                                                                                                                       |                |                                   |                  |                    |
+--------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------+----------------+-----------------------------------+------------------+--------------------+
| Pelvic floor muscle relaxation while bearing down +/− abdominal surface EMG electrodes                             |                                                                                                                                                       |                |                                   |                  |                    |
+--------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------+----------------+-----------------------------------+------------------+--------------------+
| Home training not reported                                                                                         |                                                                                                                                                       |                |                                   |                  |                    |
+--------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------+----------------+-----------------------------------+------------------+--------------------+
| Vasant *et al*., 2017[54](#jgh312207-bib-0054){ref-type="ref"}                                                     | Biofeedback with anal manometry                                                                                                                       | 45--60         | Median                            | Not stated       | Median 2 (IQR 1)   |
|                                                                                                                    |                                                                                                                                                       |                |                                   |                  |                    |
|                                                                                                                    |                                                                                                                                                       |                | 71 (IQR 42) days between sessions |                  |                    |
+--------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------+----------------+-----------------------------------+------------------+--------------------+
| Anal sphincter exercises for strength training                                                                     |                                                                                                                                                       |                |                                   |                  |                    |
+--------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------+----------------+-----------------------------------+------------------+--------------------+
| Both contraction and relaxation if indicated for dyssynergic defecation                                            |                                                                                                                                                       |                |                                   |                  |                    |
+--------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------+----------------+-----------------------------------+------------------+--------------------+
| Home training included but not described                                                                           |                                                                                                                                                       |                |                                   |                  |                    |
+--------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------+----------------+-----------------------------------+------------------+--------------------+
| Oresland *et al*., 1988[51](#jgh312207-bib-0051){ref-type="ref"}                                                   | Prior to stoma reversal                                                                                                                               | 50--60         | Not reported                      | 2--8 weeks       | Average 8 (5--10)  |
+--------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------+----------------+-----------------------------------+------------------+--------------------+
| Supervised anal sphincter training with anal pressure manometry---maximal and submaximal squeezes                  |                                                                                                                                                       |                |                                   |                  |                    |
+--------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------+----------------+-----------------------------------+------------------+--------------------+
| Pouch balloon dilatation to maximum tolerated volume for 60 s (×4--6 per session)                                  |                                                                                                                                                       |                |                                   |                  |                    |
+--------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------+----------------+-----------------------------------+------------------+--------------------+
| Home anal sphincter exercises several times daily after stoma reversal and with urge or sensation of pouch filling |                                                                                                                                                       |                |                                   |                  |                    |
+--------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------+----------------+-----------------------------------+------------------+--------------------+
| Jorge *et al*., 1994[52](#jgh312207-bib-0052){ref-type="ref"}                                                      | Prior to stoma reversal                                                                                                                               | Not reported   | Not reported                      | 5 weeks          | Not reported       |
|                                                                                                                    |                                                                                                                                                       |                |                                   |                  |                    |
|                                                                                                                    | 5‐min sessions                                                                                                                                        |                |                                   |                  |                    |
|                                                                                                                    |                                                                                                                                                       |                |                                   |                  |                    |
|                                                                                                                    | 5 times daily                                                                                                                                         |                |                                   |                  |                    |
+--------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------+----------------+-----------------------------------+------------------+--------------------+
| Maximum anal sphincter/pelvic floor muscle squeezes held for up to 10 s                                            |                                                                                                                                                       |                |                                   |                  |                    |
+--------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------+----------------+-----------------------------------+------------------+--------------------+
| Home training implied from daily sessions                                                                          |                                                                                                                                                       |                |                                   |                  |                    |
+--------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------+----------------+-----------------------------------+------------------+--------------------+
| Hull *et al*., 1995[53](#jgh312207-bib-0053){ref-type="ref"}                                                       | EMG biofeedback with perianal electrodes and manometry balloon in the pouch                                                                           | 30--45         | Not reported                      | Not reported     | Median 1 session   |
|                                                                                                                    |                                                                                                                                                       |                |                                   |                  |                    |
|                                                                                                                    |                                                                                                                                                       |                |                                   |                  | Range, 1--3        |
+--------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------+----------------+-----------------------------------+------------------+--------------------+
| Patients learned to increase pouch pressure while decreasing anal sphincter EMG activity                           |                                                                                                                                                       |                |                                   |                  |                    |
+--------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------+----------------+-----------------------------------+------------------+--------------------+
| Home training not reported                                                                                         |                                                                                                                                                       |                |                                   |                  |                    |
+--------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------+----------------+-----------------------------------+------------------+--------------------+
| Quinn *et al*., 2017[39](#jgh312207-bib-0039){ref-type="ref"}                                                      | Biofeedback training method not described but was instrument based                                                                                    | 30--60         | Week 1                            | 2 weeks          | Maximum            |
|                                                                                                                    |                                                                                                                                                       |                |                                   |                  |                    |
|                                                                                                                    |                                                                                                                                                       |                | 3 sessions daily                  |                  | 25 sessions        |
+--------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------+----------------+-----------------------------------+------------------+--------------------+
| Home training not reported                                                                                         | Week 2                                                                                                                                                |                |                                   |                  |                    |
|                                                                                                                    |                                                                                                                                                       |                |                                   |                  |                    |
|                                                                                                                    | 2 sessions daily                                                                                                                                      |                |                                   |                  |                    |
+--------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------+----------------+-----------------------------------+------------------+--------------------+
| Segal *et al*., 2018[55](#jgh312207-bib-0055){ref-type="ref"}                                                      | Individualized bowel retraining program including pelvic floor exercises and urge resistance. Biofeedback method and training protocol not described. | Not reported   | Not reported                      | 6--8 months      | Maximum 6 sessions |
+--------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------+----------------+-----------------------------------+------------------+--------------------+
| Home training included but not described                                                                           |                                                                                                                                                       |                |                                   |                  |                    |
+--------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------+----------------+-----------------------------------+------------------+--------------------+

EMG, electromyography; IQR, interquartile range.

The number of training sessions ranged from 1 to 25, delivered over periods that varied from 2 weeks to 8 months. Sessions typically lasted 30--60 min. Home training was not reported by two studies,[39](#jgh312207-bib-0039){ref-type="ref"}, [53](#jgh312207-bib-0053){ref-type="ref"} and little detail of the home training regime was provided by the remaining five studies. Segal *et al*.[55](#jgh312207-bib-0055){ref-type="ref"} was the only study to describe any additional treatment strategies provided to participants as part of the training program. These were modifications to diet and fluid intake, toileting posture, and defecation technique, as well as pelvic floor myofascial release techniques. Only one study reported the professional discipline of the therapist delivering the intervention, that is, nurse, physiotherapist, or physician.[54](#jgh312207-bib-0054){ref-type="ref"}

### *Outcome measures* {#jgh312207-sec-0021}

Outcome was assessed by patient report of improvement,[39](#jgh312207-bib-0039){ref-type="ref"}, [42](#jgh312207-bib-0042){ref-type="ref"}, [53](#jgh312207-bib-0053){ref-type="ref"}, [54](#jgh312207-bib-0054){ref-type="ref"}, [55](#jgh312207-bib-0055){ref-type="ref"} a gastrointestinal‐specific questionnaire,[42](#jgh312207-bib-0042){ref-type="ref"}, [51](#jgh312207-bib-0051){ref-type="ref"}, [52](#jgh312207-bib-0052){ref-type="ref"}, [55](#jgh312207-bib-0055){ref-type="ref"} manometric measures of anorectal or anal‐pouch function,[51](#jgh312207-bib-0051){ref-type="ref"}, [52](#jgh312207-bib-0052){ref-type="ref"} EMG,[51](#jgh312207-bib-0051){ref-type="ref"}, [53](#jgh312207-bib-0053){ref-type="ref"} bowel diary,[51](#jgh312207-bib-0051){ref-type="ref"}, [54](#jgh312207-bib-0054){ref-type="ref"} or health‐care utilization.[42](#jgh312207-bib-0042){ref-type="ref"} The questionnaires used included the short inflammatory bowel disease questionnaire (SIBDQ),[42](#jgh312207-bib-0042){ref-type="ref"} the Oresland functional score,[51](#jgh312207-bib-0051){ref-type="ref"} Cleveland fecal incontinence score,[52](#jgh312207-bib-0052){ref-type="ref"} and the International Consultation on Incontinence---Bowel questionnaire (ICIQ‐B).[55](#jgh312207-bib-0055){ref-type="ref"} Only the SIBDQ and ICIQ‐B included assessment of health‐related quality of life. Outcome assessment occurred at a wide range of intervals, from immediately following treatment to 15 months later.

*Risk of bias and study quality* {#jgh312207-sec-0022}
--------------------------------

Percentage agreement and Cohen\'s kappa statistic[56](#jgh312207-bib-0056){ref-type="ref"} were used to determine the interrater agreement of quality assessment using the MINORs (Table [3](#jgh312207-tbl-0003){ref-type="table"}) and Cochrane Risk of Bias (Table [4](#jgh312207-tbl-0004){ref-type="table"}) tools. The kappa coefficient was 0.76, indicating substantial agreement.[57](#jgh312207-bib-0057){ref-type="ref"} Reviewers had complete agreement on 46 of 54 items (85.2%) and reached consensus on the remaining 8 items before deciding the final study quality rating (poor, fair, good, excellent).

###### 

Assessment of non‐randomized study quality (MINORS)

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  MINORS criteria[†](#jgh312207-note-0005){ref-type="fn"} Clearly stated aimInclusion of consecutive patientsProspective data collectionAppropriate end‐points, intention‐to‐treat basisUnbiased assessment of study end‐pointAppropriate follow‐up period to meet aim of studyLess than 5% loss to follow‐upProspective calculation of study size
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

                                                              MINORS[†](#jgh312207-note-0007){ref-type="fn"}  Quality assessment
  ---------------------------------------------------------- ------------------------------------------------ --------------------
  IBD                                                                                                         
  Perera *et al*.[42](#jgh312207-bib-0042){ref-type="ref"}                          8                         Fair
  Vasant *et al*.[54](#jgh312207-bib-0054){ref-type="ref"}                          7                         Fair
  Pouch                                                                                                       
  Hull *et al*.[53](#jgh312207-bib-0053){ref-type="ref"}                            8                         Fair
  Quinn *et al*.[39](#jgh312207-bib-0039){ref-type="ref"}                           6                         Poor
  Segal *et al*.[55](#jgh312207-bib-0055){ref-type="ref"}                           6                         Poor

Each item is scored 0 (not reported), 1 (reported but inadequate), or 2 (reported and adequate) with an ideal score of 16.

MINORS, methodological index for nonrandomized studies.

###### 

Assessment of randomized study quality (Cochrane risk of bias)

  Jorge *et al*.[52](#jgh312207-bib-0052){ref-type="ref"}   Oresland *et al*.[51](#jgh312207-bib-0051){ref-type="ref"}   Domain[†](#jgh312207-note-0007){ref-type="fn"}
  --------------------------------------------------------- ------------------------------------------------------------ ------------------------------------------------
  ?                                                         ?                                                            Random sequence generation
  ?                                                         ?                                                            Allocation concealment
  ?                                                         ?                                                            Blinding of participants and personnel
  ?                                                         ?                                                            Blinding of outcome assessment
  ?                                                         \+                                                           Incomplete outcome data
  \+                                                        \+                                                           Selective reporting
  ?                                                         ?                                                            Other sources of bias
  Poor                                                      Fair                                                         Quality Assessment

Each domain is rated (?) = unclear risk of bias, (+) = low risk of bias, or (‐‐) = high risk of bias based on the specific criteria within each domain.

The nonrandomized studies (Table [3](#jgh312207-tbl-0003){ref-type="table"}) were limited by small numbers of participants and lack of a nonexposed cohort, blinded assessment, intention‐to‐treat analysis, missing data, or long‐term follow‐up.[39](#jgh312207-bib-0039){ref-type="ref"}, [42](#jgh312207-bib-0042){ref-type="ref"}, [53](#jgh312207-bib-0053){ref-type="ref"}, [54](#jgh312207-bib-0054){ref-type="ref"}, [55](#jgh312207-bib-0055){ref-type="ref"} The two randomized trials (Table [4](#jgh312207-tbl-0004){ref-type="table"}) were also limited by small numbers and lack of detail about random allocation method, allocation concealment, blinding of personnel, and blinding of outcome assessment.[51](#jgh312207-bib-0051){ref-type="ref"}, [52](#jgh312207-bib-0052){ref-type="ref"} Follow‐up time was inadequate in one of the randomized trials, and dropout rate was not reported.[52](#jgh312207-bib-0052){ref-type="ref"} Neither of these studies stated what exposure the control group had during the study period.

Due to these limitations, four studies were rated "fair"[42](#jgh312207-bib-0042){ref-type="ref"}, [51](#jgh312207-bib-0051){ref-type="ref"}, [53](#jgh312207-bib-0053){ref-type="ref"}, [54](#jgh312207-bib-0054){ref-type="ref"} and three "poor"[39](#jgh312207-bib-0039){ref-type="ref"}, [52](#jgh312207-bib-0052){ref-type="ref"}, [55](#jgh312207-bib-0055){ref-type="ref"} for overall quality.

*Outcomes* {#jgh312207-sec-0023}
----------

### *Evacuation difficulty---IBD* {#jgh312207-sec-0024}

Perera *et al*.[42](#jgh312207-bib-0042){ref-type="ref"} examined the outcome of biofeedback‐assisted pelvic floor training in patients with quiescent IBD and persistent evacuation problems (Table [5](#jgh312207-tbl-0005){ref-type="table"}). Although 30 patients were identified, only 22 patients underwent biofeedback‐assisted training. Patients had a mean disease duration of 14.4 ± 12.5 years. Most patients were females with Crohn\'s disease (67%). Outcome was assessed in four ways at the completion of treatment: physical therapist report of correction of dyssynergic defecation pattern, patient‐reported improvement, the shortened form of the inflammatory bowel disease questionnaire (SIBDQ), and health‐care utilization (the number of IBD‐related medical visits in the 6 months before and after treatment). Two patients dropped out of the treatment for unstated reasons and were not included in the analysis. Of the 20 remaining patients, 16 (80%) reported symptomatic improvement. The overall change in SIBDQ score was not significant, although a small proportion (30%) of patients had a clinically significant (≥7‐point) score reduction. The bowel‐related health‐care visits were significantly reduced in the 6 months following treatment compared to the 6 months prior to treatment. Six patients also had fecal urgency and/or fecal incontinence, but their outcome is not reported separately.

###### 

Pelvic floor muscle training outcomes (IBD)

+----------------------------------------------------------------+---------------------------------------------------+--------------------------------------------------------------------------------+---------------------------+-------------------------------------+---------------------------------------------------+-----------------------------------------------+-----------------------------------------------------------+
| Author, year, country and study type                           | Participants completed and dropouts               | Measure                                                                        | Preintervention Mean (SD) | Postintervention, Mean (SD)         | *P*‐value                                         | Follow‐up                                     | Outcome                                                   |
+:===============================================================+:==================================================+:===============================================================================+:==========================+:====================================+:==================================================+:==============================================+:==========================================================+
| Perera *et al*., 2013[42](#jgh312207-bib-0042){ref-type="ref"} | 20/22                                             | SIBDQ                                                                          | SIBDQ Score               | SIBDQ Score                         | 0.85                                              | At completion of treatment and 6 months later | Nil significant change in health‐ related quality of life |
|                                                                |                                                   |                                                                                |                           |                                     |                                                   |                                               |                                                           |
| USA                                                            | 2 patients did not complete therapy -- no details | HCU                                                                            | 38.6 (14.1)               | 40.3 (12.8)                         | *0.003* [\*](#jgh312207-note-0008){ref-type="fn"} |                                               | Significant reduction in HCU following training           |
|                                                                |                                                   |                                                                                |                           |                                     |                                                   |                                               |                                                           |
| Retrospective case review                                      | provided                                          | • number of health‐care visits in the 6 months prior to and following training | HCU---Visits              | HCU -- Visits                       |                                                   |                                               | Therapist report not stated                               |
|                                                                |                                                   |                                                                                |                           |                                     |                                                   |                                               |                                                           |
|                                                                |                                                   | Self‐report by therapist                                                       | 4.7 (4.2)                 | 2.7 (1.6)                           |                                                   |                                               | Improved                                                  |
|                                                                |                                                   |                                                                                |                           |                                     |                                                   |                                               |                                                           |
|                                                                |                                                   | • correction of dyssynergic pattern                                            |                           |                                     |                                                   |                                               | 16/20 (80%)                                               |
|                                                                |                                                   |                                                                                |                           |                                     |                                                   |                                               |                                                           |
|                                                                |                                                   | Patient report of improvement in symptoms                                      |                           |                                     |                                                   |                                               |                                                           |
+----------------------------------------------------------------+---------------------------------------------------+--------------------------------------------------------------------------------+---------------------------+-------------------------------------+---------------------------------------------------+-----------------------------------------------+-----------------------------------------------------------+
| Vasant *et al*., 2017[54](#jgh312207-bib-0054){ref-type="ref"} | 8/9                                               | Bowel diary                                                                    | Incontinence              | Incontinence episodes per week, 0.0 | *0.003* [\*](#jgh312207-note-0008){ref-type="fn"} | At completion of treatment                    | Improved                                                  |
|                                                                |                                                   |                                                                                |                           |                                     |                                                   |                                               |                                                           |
| UK                                                             | 1 dropout after 2 sessions                        | • episodes of fecal incontinence per week                                      | episodes per week, 11.5   |                                     |                                                   |                                               | 8/9 (89%)                                                 |
|                                                                |                                                   |                                                                                |                           |                                     |                                                   |                                               |                                                           |
| Retrospective case review                                      | (non‐responder)                                   | Patient report of full continence or improvement in symptoms                   |                           |                                     |                                                   |                                               | Fully continent                                           |
|                                                                |                                                   |                                                                                |                           |                                     |                                                   |                                               |                                                           |
|                                                                |                                                   |                                                                                |                           |                                     |                                                   |                                               | 5/9 (56%)                                                 |
+----------------------------------------------------------------+---------------------------------------------------+--------------------------------------------------------------------------------+---------------------------+-------------------------------------+---------------------------------------------------+-----------------------------------------------+-----------------------------------------------------------+

*P* \< 0.05.

HCU, health‐care utilization; IBD, inflammatory bowel disease; SIBDQ, short inflammatory bowel disease questionnaire.

### *Evacuation difficulty---Ileoanal pouch* {#jgh312207-sec-0025}

Three studies investigated the outcome of biofeedback training in patients with an ileoanal pouch and symptoms of evacuation difficulty (Table [6](#jgh312207-tbl-0006){ref-type="table"}).[39](#jgh312207-bib-0039){ref-type="ref"}, [53](#jgh312207-bib-0053){ref-type="ref"}, [55](#jgh312207-bib-0055){ref-type="ref"} Twelve patients with demonstrated paradoxical puborectalis contraction (dyssynergia) on EMG underwent biofeedback training using anal surface EMG and a pressure balloon in the pouch (Table [2](#jgh312207-tbl-0002){ref-type="table"}).[53](#jgh312207-bib-0053){ref-type="ref"} Eleven patients were followed up an average of 8 months after the completion of training. Of the 11 patients, 9 (82%) reported improvement, defined as a patient report of normal defecation and a normal EMG pattern (abolition of dyssynergia). All 11 patients had a normal defecation pattern on repeat EMG after treatment, although 2 did not report symptomatic benefit.

###### 

Pelvic floor muscle training outcomes (pouch)

+------------------------------------------------------------------+-----------------------------------------------------------------+-----------------------------------------------------------------------------------------------------+---------------------------------------------+-------------------------------------------------+--------------------------------------------------+----------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Author, year, country, and study type                            | Participants completed and dropouts                             | Measure                                                                                             | Preintervention Mean (SD)                   | Postintervention, Mean (SD)                     | *P*‐value                                        | Follow‐up                              | Outcome                                                                                                                                                     |
+:=================================================================+:================================================================+:====================================================================================================+:============================================+:================================================+:=================================================+:=======================================+:============================================================================================================================================================+
| Oresland *et al*., 1988[51](#jgh312207-bib-0051){ref-type="ref"} | Training                                                        | Maximum pouch volume                                                                                | 4 weeks after pouch construction            | Prior to stoma reversal                         | NS                                               | Before stoma closure                   | Training prior to stoma reversal did not have a significant effect on maximum pouch volume, maximum anal squeeze pressure, or maximum anal resting pressure |
|                                                                  |                                                                 |                                                                                                     |                                             |                                                 |                                                  |                                        |                                                                                                                                                             |
| Sweden                                                           | 18/20                                                           | Maximum anal resting and squeeze pressures                                                          | 75ml                                        | Training group                                  | NS                                               | 1, 3, 6, and 12 months                 | Training prior to stoma reversal did not affect functional outcome                                                                                          |
|                                                                  |                                                                 |                                                                                                     |                                             |                                                 |                                                  |                                        |                                                                                                                                                             |
| Randomized controlled trial                                      | Control                                                         | Bowel frequency per 24 h                                                                            | Maximum resting pressure                    | 136 (34) ml                                     | NS                                               | poststoma reversal                     |                                                                                                                                                             |
|                                                                  |                                                                 |                                                                                                     |                                             |                                                 |                                                  |                                        |                                                                                                                                                             |
|                                                                  | 20/20                                                           | ---bowel diary                                                                                      | 50 mmHg                                     | Control group                                   | NS                                               |                                        |                                                                                                                                                             |
|                                                                  |                                                                 |                                                                                                     |                                             |                                                 |                                                  |                                        |                                                                                                                                                             |
|                                                                  | 2 in training group withdrawn due to postoperative complication | Oresland functional score                                                                           | Maximum squeeze pressure                    | 108 (57) ml                                     | NS                                               |                                        |                                                                                                                                                             |
|                                                                  |                                                                 |                                                                                                     |                                             |                                                 |                                                  |                                        |                                                                                                                                                             |
|                                                                  |                                                                 |                                                                                                     | 170 mmHg                                    | 12 months after stoma closure                   | NS                                               |                                        |                                                                                                                                                             |
|                                                                  |                                                                 |                                                                                                     |                                             |                                                 |                                                  |                                        |                                                                                                                                                             |
|                                                                  |                                                                 |                                                                                                     | 1 week after stoma closure                  | Maximum volume both groups 265 ml               |                                                  |                                        |                                                                                                                                                             |
|                                                                  |                                                                 |                                                                                                     |                                             |                                                 |                                                  |                                        |                                                                                                                                                             |
|                                                                  |                                                                 |                                                                                                     | Training group                              | At 12 months                                    |                                                  |                                        |                                                                                                                                                             |
|                                                                  |                                                                 |                                                                                                     |                                             |                                                 |                                                  |                                        |                                                                                                                                                             |
|                                                                  |                                                                 |                                                                                                     | 7.3 (2.5)                                   | Maximum resting pressure                        |                                                  |                                        |                                                                                                                                                             |
|                                                                  |                                                                 |                                                                                                     |                                             |                                                 |                                                  |                                        |                                                                                                                                                             |
|                                                                  |                                                                 |                                                                                                     | Control group                               | Training group                                  |                                                  |                                        |                                                                                                                                                             |
|                                                                  |                                                                 |                                                                                                     |                                             |                                                 |                                                  |                                        |                                                                                                                                                             |
|                                                                  |                                                                 |                                                                                                     | 7.5 (2.5)                                   | 56 (17) mmHg                                    |                                                  |                                        |                                                                                                                                                             |
|                                                                  |                                                                 |                                                                                                     |                                             |                                                 |                                                  |                                        |                                                                                                                                                             |
|                                                                  |                                                                 |                                                                                                     | Actual scores not stated                    | Control group                                   |                                                  |                                        |                                                                                                                                                             |
|                                                                  |                                                                 |                                                                                                     |                                             |                                                 |                                                  |                                        |                                                                                                                                                             |
|                                                                  |                                                                 |                                                                                                     |                                             | 50 (15) mmHg                                    |                                                  |                                        |                                                                                                                                                             |
|                                                                  |                                                                 |                                                                                                     |                                             |                                                 |                                                  |                                        |                                                                                                                                                             |
|                                                                  |                                                                 |                                                                                                     |                                             | Maximum squeeze pressure both groups = 200 mmHg |                                                  |                                        |                                                                                                                                                             |
|                                                                  |                                                                 |                                                                                                     |                                             |                                                 |                                                  |                                        |                                                                                                                                                             |
|                                                                  |                                                                 |                                                                                                     |                                             | 6 months after stoma closure                    |                                                  |                                        |                                                                                                                                                             |
|                                                                  |                                                                 |                                                                                                     |                                             |                                                 |                                                  |                                        |                                                                                                                                                             |
|                                                                  |                                                                 |                                                                                                     |                                             | Training group                                  |                                                  |                                        |                                                                                                                                                             |
|                                                                  |                                                                 |                                                                                                     |                                             |                                                 |                                                  |                                        |                                                                                                                                                             |
|                                                                  |                                                                 |                                                                                                     |                                             | 4.9 (1.6)                                       |                                                  |                                        |                                                                                                                                                             |
|                                                                  |                                                                 |                                                                                                     |                                             |                                                 |                                                  |                                        |                                                                                                                                                             |
|                                                                  |                                                                 |                                                                                                     |                                             | Control group                                   |                                                  |                                        |                                                                                                                                                             |
|                                                                  |                                                                 |                                                                                                     |                                             |                                                 |                                                  |                                        |                                                                                                                                                             |
|                                                                  |                                                                 |                                                                                                     |                                             | 5.4 (1.8)                                       |                                                  |                                        |                                                                                                                                                             |
|                                                                  |                                                                 |                                                                                                     |                                             |                                                 |                                                  |                                        |                                                                                                                                                             |
|                                                                  |                                                                 |                                                                                                     |                                             | Actual scores not stated                        |                                                  |                                        |                                                                                                                                                             |
+------------------------------------------------------------------+-----------------------------------------------------------------+-----------------------------------------------------------------------------------------------------+---------------------------------------------+-------------------------------------------------+--------------------------------------------------+----------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Jorge *et al*., 1994[52](#jgh312207-bib-0052){ref-type="ref"}    | Training                                                        | Anal sphincter pressures                                                                            | Anal resting pressure Control               | Anal resting pressure Control                   | 0.20                                             | Within 1 month of stoma reversal       | Training prior to stoma reversal did not affect anal pressures or functional outcome soon after stoma reversal                                              |
|                                                                  |                                                                 |                                                                                                     |                                             |                                                 |                                                  |                                        |                                                                                                                                                             |
| USA                                                              | 13/13                                                           | Cleveland Fecal Incontinence score                                                                  | 65 (15) mmHg                                | 44 (14) mmHg Training                           | 0.300.07                                         |                                        |                                                                                                                                                             |
|                                                                  |                                                                 |                                                                                                     |                                             |                                                 |                                                  |                                        |                                                                                                                                                             |
| Randomized controlled trial                                      | Control                                                         |                                                                                                     | Training                                    | 48 (18) mmHg                                    |                                                  |                                        |                                                                                                                                                             |
|                                                                  |                                                                 |                                                                                                     |                                             |                                                 |                                                  |                                        |                                                                                                                                                             |
|                                                                  | 13/13                                                           |                                                                                                     | 75 (25) mmHg                                | Anal Squeeze pressure Control 110 (48) mmHg     |                                                  |                                        |                                                                                                                                                             |
|                                                                  |                                                                 |                                                                                                     |                                             |                                                 |                                                  |                                        |                                                                                                                                                             |
|                                                                  | Dropouts not reported                                           |                                                                                                     | Anal Squeeze pressure Control 128 (52) mmHg | Training 86 (44) mmHg                           |                                                  |                                        |                                                                                                                                                             |
|                                                                  |                                                                 |                                                                                                     |                                             |                                                 |                                                  |                                        |                                                                                                                                                             |
|                                                                  |                                                                 |                                                                                                     | Training 97 (48) mmHg                       | Control 2.8 (1.6)                               |                                                  |                                        |                                                                                                                                                             |
|                                                                  |                                                                 |                                                                                                     |                                             |                                                 |                                                  |                                        |                                                                                                                                                             |
|                                                                  |                                                                 |                                                                                                     | Control 0.2 (0.1)Training 0.2 (1.2)         | Training 2.0 (1.2)                              |                                                  |                                        |                                                                                                                                                             |
+------------------------------------------------------------------+-----------------------------------------------------------------+-----------------------------------------------------------------------------------------------------+---------------------------------------------+-------------------------------------------------+--------------------------------------------------+----------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Hull *et al*.,1995[53](#jgh312207-bib-0053){ref-type="ref"}      | 12/13                                                           | Patient report of symptom resolution and normal EMG                                                 | None reported                               | None reported                                   | Not reported                                     | Average follow‐up                      | Improved                                                                                                                                                    |
|                                                                  |                                                                 |                                                                                                     |                                             |                                                 |                                                  |                                        |                                                                                                                                                             |
| USA                                                              | 1 patient was lost to follow‐up                                 |                                                                                                     |                                             |                                                 |                                                  | 8 months                               | 9/12 (75%)                                                                                                                                                  |
|                                                                  |                                                                 |                                                                                                     |                                             |                                                 |                                                  |                                        |                                                                                                                                                             |
| Prospective case series                                          |                                                                 |                                                                                                     |                                             |                                                 |                                                  | Range, 1--15                           | No change                                                                                                                                                   |
|                                                                  |                                                                 |                                                                                                     |                                             |                                                 |                                                  |                                        |                                                                                                                                                             |
|                                                                  |                                                                 |                                                                                                     |                                             |                                                 |                                                  |                                        | 2/12 (17%)                                                                                                                                                  |
|                                                                  |                                                                 |                                                                                                     |                                             |                                                 |                                                  |                                        |                                                                                                                                                             |
|                                                                  |                                                                 |                                                                                                     |                                             |                                                 |                                                  |                                        | All 11 normalized EMG                                                                                                                                       |
+------------------------------------------------------------------+-----------------------------------------------------------------+-----------------------------------------------------------------------------------------------------+---------------------------------------------+-------------------------------------------------+--------------------------------------------------+----------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Quinn *et al*., 2017[39](#jgh312207-bib-0039){ref-type="ref"}    | 22/33                                                           | Patient rating 15‐point Likert scale                                                                | Not reported                                | Change in patient rating scale                  | Not reported                                     | At completion of training              | Significant improvement                                                                                                                                     |
|                                                                  |                                                                 |                                                                                                     |                                             |                                                 |                                                  |                                        |                                                                                                                                                             |
| USA                                                              | 7 dropped out due to pain with treatment                        | −7 "a great deal worse"                                                                             |                                             | +4.6                                            |                                                  |                                        | 5/22 (23%)                                                                                                                                                  |
|                                                                  |                                                                 |                                                                                                     |                                             |                                                 |                                                  |                                        |                                                                                                                                                             |
| Retrospective case series                                        | 3 with time constraints                                         | 0 "no change"                                                                                       |                                             |                                                 |                                                  |                                        | Mild--moderate improvement                                                                                                                                  |
|                                                                  |                                                                 |                                                                                                     |                                             |                                                 |                                                  |                                        |                                                                                                                                                             |
|                                                                  | 1 due to lack of progress                                       | \+ 7 "a very great deal better"                                                                     |                                             |                                                 |                                                  |                                        | 15/22 (68%)                                                                                                                                                 |
|                                                                  |                                                                 |                                                                                                     |                                             |                                                 |                                                  |                                        |                                                                                                                                                             |
|                                                                  |                                                                 | Physician rating of improvement                                                                     |                                             |                                                 |                                                  |                                        | No change                                                                                                                                                   |
|                                                                  |                                                                 |                                                                                                     |                                             |                                                 |                                                  |                                        |                                                                                                                                                             |
|                                                                  |                                                                 | "significant improvement"                                                                           |                                             |                                                 |                                                  |                                        | 2/22 (9%)                                                                                                                                                   |
|                                                                  |                                                                 |                                                                                                     |                                             |                                                 |                                                  |                                        |                                                                                                                                                             |
|                                                                  |                                                                 | "mild--moderate improvement"                                                                        |                                             |                                                 |                                                  |                                        |                                                                                                                                                             |
|                                                                  |                                                                 |                                                                                                     |                                             |                                                 |                                                  |                                        |                                                                                                                                                             |
|                                                                  |                                                                 | "no change"                                                                                         |                                             |                                                 |                                                  |                                        |                                                                                                                                                             |
+------------------------------------------------------------------+-----------------------------------------------------------------+-----------------------------------------------------------------------------------------------------+---------------------------------------------+-------------------------------------------------+--------------------------------------------------+----------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Segal *et al*., 2018[55](#jgh312207-bib-0055){ref-type="ref"}    | 24/24                                                           | Subjective improvement rating by 2 independent reviewers from patient reports in the medical record | Not relevant                                | Not reported                                    | Not reported                                     | Median follow‐up                       | *FI*                                                                                                                                                        |
|                                                                  |                                                                 |                                                                                                     |                                             |                                                 |                                                  |                                        |                                                                                                                                                             |
| UK                                                               | Objective data available for only 9/24 patients                 | ICIQ‐B questionnaire                                                                                | FI Group                                    | 46 (39--62)                                     | 0.12                                             | 3 months from last biofeedback session | Much improved                                                                                                                                               |
|                                                                  |                                                                 |                                                                                                     |                                             |                                                 |                                                  |                                        |                                                                                                                                                             |
| Retrospective case series                                        |                                                                 | Bowel pattern                                                                                       | *n = 5/16*                                  | 53 (11--76)                                     | 0.21                                             | Range, 1--6 months                     | 4/16 25%                                                                                                                                                    |
|                                                                  |                                                                 |                                                                                                     |                                             |                                                 |                                                  |                                        |                                                                                                                                                             |
|                                                                  |                                                                 | Bowel control                                                                                       | Median (range)62 (49--62)                   | 29 (12--29)                                     | 0.35                                             |                                        | Some improvement                                                                                                                                            |
|                                                                  |                                                                 |                                                                                                     |                                             |                                                 |                                                  |                                        |                                                                                                                                                             |
|                                                                  |                                                                 | Nonscored                                                                                           | 82 (33--102)                                | 41 (30--55)                                     | *0.01* [\*](#jgh312207-note-0009){ref-type="fn"} |                                        | 8/16 50%                                                                                                                                                    |
|                                                                  |                                                                 |                                                                                                     |                                             |                                                 |                                                  |                                        |                                                                                                                                                             |
|                                                                  |                                                                 | Quality of life                                                                                     | 22 (17--35)                                 | Incomplete emptying                             | Not reported                                     |                                        | No improvement                                                                                                                                              |
|                                                                  |                                                                 |                                                                                                     |                                             |                                                 |                                                  |                                        |                                                                                                                                                             |
|                                                                  |                                                                 | St Marks tool for ED                                                                                | 80 (62--98)                                 | 4/4 (100%)                                      |                                                  |                                        | 4/16 25%                                                                                                                                                    |
|                                                                  |                                                                 |                                                                                                     |                                             |                                                 |                                                  |                                        |                                                                                                                                                             |
|                                                                  |                                                                 |                                                                                                     | ED Group                                    | Straining                                       |                                                  |                                        | *ED*                                                                                                                                                        |
|                                                                  |                                                                 |                                                                                                     |                                             |                                                 |                                                  |                                        |                                                                                                                                                             |
|                                                                  |                                                                 |                                                                                                     | *n = 4/8*                                   | 2/4 (50%)                                       |                                                  |                                        | Much improved                                                                                                                                               |
|                                                                  |                                                                 |                                                                                                     |                                             |                                                 |                                                  |                                        |                                                                                                                                                             |
|                                                                  |                                                                 |                                                                                                     | Incomplete emptying                         | Pain                                            |                                                  |                                        | 4/8 50%                                                                                                                                                     |
|                                                                  |                                                                 |                                                                                                     |                                             |                                                 |                                                  |                                        |                                                                                                                                                             |
|                                                                  |                                                                 |                                                                                                     | 4/4 (100%)                                  | 1/4 (25%)                                       |                                                  |                                        | Some improvement                                                                                                                                            |
|                                                                  |                                                                 |                                                                                                     |                                             |                                                 |                                                  |                                        |                                                                                                                                                             |
|                                                                  |                                                                 |                                                                                                     | Straining                                   | Bloating                                        |                                                  |                                        | 2/8 25%                                                                                                                                                     |
|                                                                  |                                                                 |                                                                                                     |                                             |                                                 |                                                  |                                        |                                                                                                                                                             |
|                                                                  |                                                                 |                                                                                                     | 4/4 (100%)                                  | 2/4 (50%)                                       |                                                  |                                        | No improvement                                                                                                                                              |
|                                                                  |                                                                 |                                                                                                     |                                             |                                                 |                                                  |                                        |                                                                                                                                                             |
|                                                                  |                                                                 |                                                                                                     | Pain                                        | Laxatives                                       |                                                  |                                        | 2/8 25%                                                                                                                                                     |
|                                                                  |                                                                 |                                                                                                     |                                             |                                                 |                                                  |                                        |                                                                                                                                                             |
|                                                                  |                                                                 |                                                                                                     | 4/4 (100%)                                  | 0/4 (0%)                                        |                                                  |                                        | Combined outcome                                                                                                                                            |
|                                                                  |                                                                 |                                                                                                     |                                             |                                                 |                                                  |                                        |                                                                                                                                                             |
|                                                                  |                                                                 |                                                                                                     | Bloating                                    |                                                 |                                                  |                                        | *(FI and ED)*                                                                                                                                               |
|                                                                  |                                                                 |                                                                                                     |                                             |                                                 |                                                  |                                        |                                                                                                                                                             |
|                                                                  |                                                                 |                                                                                                     | 3/4 (75%)                                   |                                                 |                                                  |                                        | Improved 75%                                                                                                                                                |
|                                                                  |                                                                 |                                                                                                     |                                             |                                                 |                                                  |                                        |                                                                                                                                                             |
|                                                                  |                                                                 |                                                                                                     | Laxatives                                   |                                                 |                                                  |                                        |                                                                                                                                                             |
|                                                                  |                                                                 |                                                                                                     |                                             |                                                 |                                                  |                                        |                                                                                                                                                             |
|                                                                  |                                                                 |                                                                                                     | 1/4 (25%)                                   |                                                 |                                                  |                                        |                                                                                                                                                             |
+------------------------------------------------------------------+-----------------------------------------------------------------+-----------------------------------------------------------------------------------------------------+---------------------------------------------+-------------------------------------------------+--------------------------------------------------+----------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------+

*P* \< 0.05.

ED, evacuation disorder; EMG, electromyography; FI, fecal incontinence; ICIQ, International Consultation on Incontinence questionnaire‐bowel; NS, not significant.

Eighty‐three patients with an ileoanal pouch and symptoms of evacuation difficulty were identified with nonrelaxing pelvic floor muscle dysfunction by Quinn *et al*.[39](#jgh312207-bib-0039){ref-type="ref"} (Table [6](#jgh312207-tbl-0006){ref-type="table"}). Of these patients, 33 had biofeedback training, with 22 (67%) patients completing the training program. Seven patients ceased treatment due to pain during therapy. The biofeedback method was not described but may have been invasive (electrodes or balloons inserted per anum), and training was intensive, occurring over a 2‐ week period. Three others withdrew due to time limitations and one due to lack of improvement. The outcome was recorded at the end of the 2‐week training period with no longer‐term follow‐up. Of 22 patients who completed therapy, 20 (91%) had symptomatic improvement as assessed by both the patient and physician.

Segal *et al*.[55](#jgh312207-bib-0055){ref-type="ref"} used two independent reviewers to determine improvement from reports in the medical record for eight patients with an ileoanal pouch and problems with evacuation. The kappa coefficient for interrater reliability was high (0.94). Specific details of the biofeedback‐assisted pelvic floor training program were not reported, but six (75%) of eight patients were reported to have improved at a median of 3 months from their last training session. A tool for assessing evacuation disorders was also used by these researchers but was only completed by four of the eight patients at the completion of treatment. Symptoms of abdominal pain, bloating, and straining reduced, but incomplete emptying was unchanged (Table [6](#jgh312207-tbl-0006){ref-type="table"}).

### *Fecal incontinence---IBD* {#jgh312207-sec-0026}

The outcome of biofeedback‐assisted pelvic floor muscle training in a group of nine patients with quiescent IBD (Table [5](#jgh312207-tbl-0005){ref-type="table"}) was measured by patient report of symptomatic improvement and fecal incontinence episodes per week using a bowel diary.[54](#jgh312207-bib-0054){ref-type="ref"} Only patients who had completed biofeedback training were included in this study. The authors did not state whether there were other patients who had not completed training and had been excluded. Patients were divided into responders and nonresponders according to outcome. Responders were those achieving continence or reporting significant improvement. Eight responders (89%) achieved a significant reduction in the median number of fecal incontinence episodes Five patients (56%) achieved full continence. The single nonresponder dropped out of the treatment after two sessions. Two patients were found to have a dyssynergic defecation pattern on manometry testing, and both improved with treatment. Six patients had documented reports of performing home exercises as instructed. There was no long‐term follow‐up.

Segal *et al*.[55](#jgh312207-bib-0055){ref-type="ref"} included 16 patients with an ileoanal pouch and fecal incontinence in their retrospective case review. The outcome of the biofeedback training program, at a median of 3 months following treatment completion, was assessed using two independent reviewers to determine improvement from reports in the medical record, patient report of improvement, or the ICIQ‐B questionnaire (Table [6](#jgh312207-tbl-0006){ref-type="table"}). Symptom improvement was reported in 12 (75%) of 16 cases, but ICIQ‐B scores were only available for 5 (31%) of the 16 participants. The quality‐of‐life domain of the ICIQ‐B was the only domain in this questionnaire that changed significantly (*P* = 0.01).

### *Fecal incontinence---Ileoanal pouch* {#jgh312207-sec-0027}

The RCTs recruited consecutive patients with an ileoanal pouch prior to stoma reversal and assessed the effect of different training protocols on anal sphincter muscle function and pouch function after reversal.[51](#jgh312207-bib-0051){ref-type="ref"}, [52](#jgh312207-bib-0052){ref-type="ref"} Jorge *et al*.[52](#jgh312207-bib-0052){ref-type="ref"} randomized 26 patients, with 13 patients in each group, to the training or control group. Those in the training group were asked to perform anal sphincter (pelvic floor) exercises five times daily for up to 5 weeks prior to stoma reversal (Table [6](#jgh312207-tbl-0006){ref-type="table"}). The authors did not state if patients were shown how to perform the exercises correctly, and biofeedback was not used. Patients were assessed at baseline and within a month of stoma reversal using anal manometry and the Cleveland fecal incontinence score. There were no significant differences between groups in anal resting pressure (*P* = 0.20) or anal squeeze pressure (*P* = 0.30). The training group had a lower mean fecal incontinence score (2.0) than the control group (2.8), but this did not reach significance (*P* = 0.07).

The second randomized trial used repeated progressive pouch dilatations with a balloon and biofeedback‐guided anal sphincter exercises for 2--8 weeks prior to stoma reversal.[51](#jgh312207-bib-0051){ref-type="ref"} Forty patients were randomized, with 20 patients in the training group and 20 in the control group. Two patients were lost from the training group due to surgical complications. Outcomes were assessed at multiple time points for up to 12 months following stoma reversal. These included bowel frequency using a daily diary, a questionnaire (the Oresland score) devised to assess functional outcome (lower score equals better outcome), anal sphincter pressures, and maximum pouch volume (Table [6](#jgh312207-tbl-0006){ref-type="table"}). Pouch volume, anal resting pressure, anal squeeze pressure, and bowel frequency did not differ significantly between groups at any time point. The training group had a lower Oresland score than the control group at 6 and 12 months following stoma reversal but, again, did not reach significance.

### *Summary* {#jgh312207-sec-0028}

The total number of patients receiving anal sphincter or pelvic floor muscle training for evacuation problems was 76, with 61 (80%) of these 76 completing training and 51 (84%) of these 61 reported as improved. The improvement rate for the total cohort when including treatment dropouts was 67% (51 of 76), 65% (35 of 54) for those with an ileoanal pouch, and 73% (16 of 22) for those with quiescent IBD.

The total number of patients receiving anal sphincter or pelvic floor muscle training for fecal incontinence was 25, with 24 (96%) of these 25 completing training and 20 (83%) of 24 reporting as improved. The improvement rate for this cohort, including dropouts, was 20 (80%) of 25 patients.

Pelvic floor muscle training prior to stoma reversal in patients with an ileoanal pouch did not significantly reduce fecal incontinence or improve pouch function following stoma closure compared to the control groups.

Discussion {#jgh312207-sec-0029}
==========

This review aimed to systematically evaluate the evidence for pelvic floor muscle training in the management of impaired evacuation or fecal incontinence in patients with quiescent IBD. Although pelvic floor muscle training is well validated in the non‐IBD setting, its application in the IBD population has been neglected. Only two RCTs and five nonrandomized studies were considered eligible after a comprehensive literature search.

The nonrandomized studies reported a decrease in bowel symptoms (fecal incontinence or defecation difficulty) after training in 65--80% of patients.[39](#jgh312207-bib-0039){ref-type="ref"}, [42](#jgh312207-bib-0042){ref-type="ref"}, [53](#jgh312207-bib-0053){ref-type="ref"}, [54](#jgh312207-bib-0054){ref-type="ref"}, [55](#jgh312207-bib-0055){ref-type="ref"} While outcomes immediately following treatment were encouraging, there were significant limitations in some of the studies. In one study, less than half (33 of 83) of the patients identified with nonrelaxing pelvic floor muscle dysfunction had biofeedback training.[39](#jgh312207-bib-0039){ref-type="ref"} It is unknown why 50 were excluded and whether those treated had pouchitis or not. One third did not complete treatment, seven due to pain. The type of intervention was not described, and treatment dropouts were not included in the final analysis.

Another study did not describe whether their screening process excluded pouchitis or other types of pouch dysfunction prior to treatment.[55](#jgh312207-bib-0055){ref-type="ref"} Objective data were missing in the final analysis, with most data coming from patient reports found in the medical record.

Long‐term follow‐up (≥12 months) to determine whether treatment effect was sustained was reported in just one study.[52](#jgh312207-bib-0052){ref-type="ref"} The manometric measures of anal sphincter function in those with fecal incontinence did not improve with training despite symptomatic improvement. This lack of correlation between symptomatic improvement and physiological measures following biofeedback training is consistent with previous studies in non‐IBD patients.[58](#jgh312207-bib-0058){ref-type="ref"}, [59](#jgh312207-bib-0059){ref-type="ref"}

The RCTs[51](#jgh312207-bib-0051){ref-type="ref"}, [52](#jgh312207-bib-0052){ref-type="ref"} failed to show that pelvic floor or anal sphincter muscle training in patients with an ileoanal pouch, prior to stoma closure, reduces the risk, or severity, of fecal incontinence poststoma reversal. These studies may have been limited by small participant numbers as, in both studies, outcomes tended to favor the intervention group but did not reach significance. Oresland *et al*.[51](#jgh312207-bib-0051){ref-type="ref"} used pouch balloon dilatation for pouch stretching, which may also have been a means of improving the awareness of pouch contents or improving pelvic floor muscle response to urge or sense of pouch fullness. In both controlled, randomized trials, it was unclear what exposure the control groups may have had during the study to personnel, medication, or self‐initiated pelvic floor exercises.

Limitations of the studies included in this systematic review are study design, small participant numbers, missing data, and lack of blinded assessment and long‐term follow‐up. It is possible that the effects observed were due to natural recovery or other factors such as patient education and support, medications, or interaction with a therapist. Patient adherence to the training protocols was not reported. There was wide variation in training protocols and follow‐up duration. There was insufficient evidence to determine whether pelvic floor muscle exercises alone are as effective as biofeedback‐assisted training or whether one training protocol is more effective than another.

A recent systematic review and meta‐analysis on the prevalence, diagnosis, and management of dyssynergic defecation in patients with IBD and symptoms of defecatory dysfunction concluded that symptoms of evacuation difficulty in patients with quiescent IBD do respond to biofeedback training.[5](#jgh312207-bib-0005){ref-type="ref"} That systematic review included patients with an ileoanal pouch from a single center, possibly a single patient cohort, published in three separate abstracts,[41](#jgh312207-bib-0041){ref-type="ref"}, [60](#jgh312207-bib-0060){ref-type="ref"}, [61](#jgh312207-bib-0061){ref-type="ref"} all of which were included in the meta‐analysis. The review did not include details about patient selection, treatment provided, outcome measures used, follow‐up periods, dropout rates, or the criteria used to assess study quality.

A second systematic review and meta‐analysis by the same research team on the prevalence, diagnosis, and management of fecal incontinence in patients with IBD did not report on pelvic floor muscle training and/or biofeedback.[12](#jgh312207-bib-0012){ref-type="ref"}

We have not conducted a meta‐analysis as there were insufficient studies to do so. The existing studies varied too much in their methodologies to be combined into one analysis. Studies should include full descriptions of the interventions delivered. This allows clinicians to implement the interventions more effectively and for researchers to replicate them in future studies, providing more meaningful outcome analyses.

There are good clinical reasons for offering pelvic floor muscle training, with or without biofeedback, to patients with mild or quiescent IBD and persistent bowel symptoms despite the lack of published evidence. Published guidelines for the management of fecal incontinence recognize that both IBD and bowel surgery increase the risk of developing fecal incontinence.[62](#jgh312207-bib-0062){ref-type="ref"}, [63](#jgh312207-bib-0063){ref-type="ref"} The sensorimotor function of the anorectum may be affected by the inflammatory process, with alterations in the sensory perception of rectal contents and the ability to contain or expel contents.[23](#jgh312207-bib-0023){ref-type="ref"}, [24](#jgh312207-bib-0024){ref-type="ref"} Surgical procedures or perianal fistulae may further compromise anal sphincter function.

Pelvic floor muscle training is not purely strength training. It incorporates exercises for improving the awareness of muscle contraction and relaxation, endurance, and coordination with abdominal and diaphragm muscles for the normal functions of continence and effective defecation. Nonrelaxing pelvic floor muscle dysfunction may develop in response to pain, urgency, or diarrhea as a protective mechanism.[36](#jgh312207-bib-0036){ref-type="ref"} The muscles develop abnormal behavior through prolonged periods of holding on, which may eventually compromise their ability to contract and relax effectively. Muscle contraction strength in shortened, tight, or tense muscles is diminished.[64](#jgh312207-bib-0064){ref-type="ref"} This can affect both continence and the ability to evacuate effectively. Symptoms do not correlate well with underlying pathophysiology, and there is no single standardized test for diagnosing pelvic floor muscle dysfunction. It is widely accepted that a combination of tests is required and includes skilled digital examination, anal manometry, balloon expulsion testing, EMG, defecography, or ultrasound.[45](#jgh312207-bib-0045){ref-type="ref"}, [65](#jgh312207-bib-0065){ref-type="ref"} Nonrelaxing pelvic floor muscle dysfunction has been demonstrated in patients with IBD,[41](#jgh312207-bib-0041){ref-type="ref"}, [42](#jgh312207-bib-0042){ref-type="ref"} and pelvic floor muscle training, often assisted by biofeedback, is the key therapy recommended.[37](#jgh312207-bib-0037){ref-type="ref"}, [38](#jgh312207-bib-0038){ref-type="ref"}, [66](#jgh312207-bib-0066){ref-type="ref"} Noninvasive forms of biofeedback such as external EMG or real‐time ultrasound imaging may be preferable in this patient cohort to prevent patients withdrawing from therapy due to discomfort.[60](#jgh312207-bib-0060){ref-type="ref"} It is a safe and effective treatment in the non‐IBD population with results maintained in the long term.[45](#jgh312207-bib-0045){ref-type="ref"}

Pelvic floor muscle training, with or without biofeedback, is often combined with other conservative interventions, including education, dietary and medication advice, toileting behavior modifications, urge resistance or deferral techniques, lifestyle changes, emotional support, and practical management strategies. Usually referred to as behavioral treatment, this package of care is tailored by the therapist to address individual patient symptoms. The education and psychological support provided by a therapist during training sessions as well as the skill and experience of the therapist may be key factors contributing to the efficacy of treatment.[58](#jgh312207-bib-0058){ref-type="ref"}, [67](#jgh312207-bib-0067){ref-type="ref"}, [68](#jgh312207-bib-0068){ref-type="ref"}, [69](#jgh312207-bib-0069){ref-type="ref"} There is only one published study investigating behavioral treatment in the management of bowel dysfunction in patients with quiescent IBD, a study in patients with an ileoanal pouch.[55](#jgh312207-bib-0055){ref-type="ref"}

In conclusion, this review suggests that symptomatic benefit can be achieved with pelvic floor muscle training in patients with quiescent IBD and bowel dysfunction, but the current evidence is limited. Despite the limitations of the current evidence, pelvic floor muscle training is a safe intervention that can be provided to patients with IBD or an ileoanal pouch without risk of serious adverse effects. Patients most likely to benefit have fecal incontinence or impaired evacuation and demonstrate pelvic floor or anal sphincter muscle dysfunction. Active inflammation and anal or anastomotic strictures should be excluded. Training programs that are individualized to target existing symptoms and muscle deficits and that adhere to exercise training principles are recommended. Given the prevalence and impact of functional bowel symptoms in patients with quiescent IBD and the potential benefit of gut‐directed behavioral treatment, including pelvic floor muscle training, prospective trials that may include standardized pelvic floor muscle assessment, health‐related quality of life measures, and long‐term follow‐up are urgently needed. This could help develop better‐targeted therapies for patients with IBD and persistent bowel symptoms despite drug‐ or surgically induced remission.
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